The Business of March Madness
Airtime: Thurs. Mar. 18 2010 |
The NCAA men’s basketball tournament is getting underway, and CNBC’s Darren Rovell looks at the business behind the madness. He’s joined by Greg Shaleen, NCAA SVP.
Airtime: Thurs. Mar. 18 2010 |
The NCAA men’s basketball tournament is getting underway, and CNBC’s Darren Rovell looks at the business behind the madness. He’s joined by Greg Shaleen, NCAA SVP.
The Bank of England left interest rates and its asset purchasing program unchanged Monday. Justin Urquhart Stewart from Seven Investment Management and David Frost, director general of British Chambers of Commerce, joined the discussion.
CNBC’s Annette Weisbach breaks down today’s European market action.
SEC Chairman Mary Schapiro discusses financial regulatory reform with CNBC’s Maria Bartiromo.
The UK has one of the highest personal tax systems in the world after the top rate of income tax was raised to 50% Tuesday. Jeremy Cape from Denton Wilde Sapte and David Brunning from Brunning Newman Houghton discuss
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
A look at the V-shaped indicators, with Don Luskin, Trend Macro; Stefan Abrams, Bryden-Adams Investment and Brian Wesbury, First Trust Advisors.